Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions NGN. Fiscal year is April - March.

Millions NGN. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2016 - 2020
Market Capitalization	702	863	286	77	77	77	Upgrade
Market Cap Growth	-30.00%	201.85%	271.43%	-	-	52.17%	Upgrade
Enterprise Value	1,026	1,174	547	538	538	538	Upgrade
Last Close Price	3.19	2.18	0.72	0.19	0.19	0.19	Upgrade
PE Ratio	-	-	7.78	1.04	4.67	-	Upgrade
PS Ratio	9.80	10.75	3.28	1.08	1.37	1.00	Upgrade
PB Ratio	1.69	1.69	0.55	0.16	-0.20	-0.19	Upgrade
P/TBV Ratio	1.95	1.95	0.59	0.17	-	-	Upgrade
P/FCF Ratio	-	-	-	-	1.85	-	Upgrade
P/OCF Ratio	-	45.58	-	-	1.77	-	Upgrade
EV/Sales Ratio	14.32	14.62	6.28	7.54	9.55	6.99	Upgrade
EV/EBITDA Ratio	-	49.04	8.45	110.98	-	-	Upgrade
EV/EBIT Ratio	-	624.45	12.56	-	-	-	Upgrade
EV/FCF Ratio	-	-	-	-	12.94	-	Upgrade
Debt / Equity Ratio	0.66	0.54	0.53	0.57	-1.22	-1.17	Upgrade
Debt / EBITDA Ratio	-	11.49	4.25	56.73	-	-	Upgrade
Debt / FCF Ratio	-	-	-	-	11.06	-	Upgrade
Asset Turnover	-	0.08	0.08	0.09	0.13	0.19	Upgrade
Inventory Turnover	-	6.77	10.57	5.87	4.39	9.16	Upgrade
Quick Ratio	0.09	0.12	0.17	0.42	0.19	0.08	Upgrade
Current Ratio	0.13	0.19	0.22	0.44	0.25	0.11	Upgrade
Return on Equity (ROE)	-	-2.41%	8.58%	160.36%	-	-	Upgrade
Return on Assets (ROA)	-	0.11%	2.50%	-1.09%	-9.42%	-7.77%	Upgrade
Return on Capital (ROIC)	-	0.15%	3.50%	-2.07%	-53.91%	-34.93%	Upgrade
Return on Capital Employed (ROCE)	-	0.20%	5.20%	-	-	-	Upgrade
Earnings Yield	-10.19%	-4.65%	12.85%	96.55%	21.43%	-67.45%	Upgrade
FCF Yield	-	-0.66%	-7.20%	-47.82%	54.02%	-1.98%	Upgrade
Buyback Yield / Dilution	-	-	-0.62%	7.20%	-8.85%	1.61%	Upgrade

Updated May 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.